Valuation: Acotec Scientific Holdings Limited

Market Cap 2.21B 2.55B 326M 285M 262M 244M 463M 31.01B 470M 3.14B 1.22B 15.24B 1.22B 1.2B 52.52B P/E 2026 *
16.4x
P/E 2027 * 13.1x
Enterprise Value 2.21B 2.55B 326M 285M 262M 244M 463M 31.01B 470M 3.14B 1.22B 15.24B 1.22B 1.2B 52.52B EV / Sales 2026 *
3.04x
EV / Sales 2027 * 2.43x
Free-Float
16.21%
Yield 2026 *
-
Yield 2027 * -
1 day+7.95%
1 week+5.57%
Current month+2.00%
1 month-9.44%
3 months-37.31%
6 months-40.64%
Current year-39.63%
1 week 7.54
Extreme 7.54
8.45
1 month 7.54
Extreme 7.54
8.88
Current year 7.54
Extreme 7.54
15.32
1 year 7.54
Extreme 7.54
15.47
3 years 5.26
Extreme 5.26
15.47
5 years 4.21
Extreme 4.21
19.88
10 years 4.21
Extreme 4.21
19.88
Manager TitleAgeSince
Chief Executive Officer 54 28/01/2021
Chief Tech/Sci/R&D Officer 48 28/01/2021
Chief Tech/Sci/R&D Officer 85 28/01/2021
Director TitleAgeSince
Director/Board Member 53 31/07/2021
Director/Board Member 54 28/01/2021
Director/Board Member 55 08/02/2023
Date Insider Type Main position Quantity % Market Cap.
07/06/23Other

Chief Executive Officer

7,208,000 2.3000%
23/09/21Other

Chief Executive Officer

342,000 0.1091%
Change 5-day change 1-year change 3-year change Capi.($)
+7.95%+5.57%-10.93%-38.72% 326M
+0.68%+0.61%+26.89%-5.96% 12.53B
+2.20%+3.73%+68.22%+38.99% 6.36B
+1.56%+5.29%+7.94%+11.68% 5.87B
+2.63%+9.48% - - 4.38B
-0.16%+7.39%-33.21%+6.30% 4.05B
+1.60%+3.99%-25.41%-24.73% 3.91B
+9.00%+11.47%-2.88%-59.39% 1.99B
+1.43%+4.40%+26.23%+232.99% 1.88B
+0.94%+0.54%+60.70%-7.25% 1.55B
Average +2.78%+4.72%+13.06%+17.10% 4.28B
Weighted average by Cap. +1.71%+3.61%+18.65%+12.13%

Financials

2026 *2027 *
Net sales 728M 841M 107M 93.76M 86.17M 80.32M 152M 10.21B 155M 1.03B 402M 5.02B 403M 394M 17.3B 910M 1.05B 134M 117M 108M 100M 190M 12.76B 193M 1.29B 503M 6.27B 503M 492M 21.62B
Net income 128M 148M 18.86M 16.49M 15.15M 14.12M 26.78M 1.8B 27.19M 182M 70.7M 883M 70.78M 69.26M 3.04B 164M 190M 24.16M 21.12M 19.41M 18.09M 34.32M 2.3B 34.84M 233M 90.59M 1.13B 90.69M 88.74M 3.9B
Net Debt - -
Logo Acotec Scientific Holdings Limited
Acotec Scientific Holdings Ltd is a company engaged in interventional medical device business. The Company is primarily engaged in the research and development on providing treatment solutions for vascular diseases, involving drug-coated balloons (DCB) and percutaneous transluminal angioplasty balloon catheters (PTA). The Company’s main products include AcoArt Orchid & Dhalia, AcoArt Tulip & Litos, AcoArt Iris & Jasmin, AcoArt Lily & Rosmarin, Peripheral Aspiration System (AcoStream), Radiofrequency Ablation System (AcoArt Cedar), 2nd Gen Peripheral Aspiration System (2nd Generation AcoStream) and others, covering fields such as vascular surgery, cardiology, nephrology and neurology. The Company conducts its businesses within domestic and overseas markets.
Employees
653
Date Price Change Volume
03/07/26 HK$8.150 +7.95% 435,580
02/07/26 HK$7.550 -5.51% 528,000
30/06/26 HK$7.990 -3.50% 345,577
29/06/26 HK$8.280 +7.25% 373,388
26/06/26 HK$7.720 -0.39% 331,642
Trader
-
Investor
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
7.053CNY
Average target price
15.00CNY
Spread / Average Target
+112.63%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6669 Stock